Bionano Genomics Inc (BNGO)
0.759
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 16:00
0.75
-0.01
(-1.19%)
After-Hours: 20:00
Bionano Genomics Free Cash Flow (Quarterly): -30.52M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -30.52M |
| September 30, 2023 | -26.37M |
| June 30, 2023 | -37.21M |
| March 31, 2023 | -32.77M |
| December 31, 2022 | -36.08M |
| September 30, 2022 | -29.76M |
| June 30, 2022 | -28.80M |
| March 31, 2022 | -33.48M |
| December 31, 2021 | -26.74M |
| September 30, 2021 | -20.25M |
| June 30, 2021 | -12.47M |
| March 31, 2021 | -13.93M |
| December 31, 2020 | -12.10M |
| September 30, 2020 | -10.96M |
| Date | Value |
|---|---|
| June 30, 2020 | -7.218M |
| March 31, 2020 | -8.032M |
| December 31, 2019 | -9.405M |
| September 30, 2019 | -7.288M |
| June 30, 2019 | -6.346M |
| March 31, 2019 | -6.552M |
| December 31, 2018 | -4.102M |
| September 30, 2018 | -6.230M |
| June 30, 2018 | -3.144M |
| March 31, 2018 | -6.799M |
| December 31, 2017 | -3.091M |
| September 30, 2017 | -5.929M |
| June 30, 2017 | -5.378M |
| March 31, 2017 | -7.437M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-37.21M
Minimum
Jun 2023
-6.346M
Maximum
Jun 2019
-20.51M
Average
-20.25M
Median
Sep 2021
Free Cash Flow (Quarterly) Benchmarks
| Bruker Corp | 174.00M |
| Azenta Inc | 14.51M |
| Harvard Bioscience Inc | 3.242M |
| Akoya Biosciences Inc | -6.178M |
| Singular Genomics Systems Inc | -19.29M |